#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14288	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2102	674.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1432	1432	C	838	C,A	781,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26316	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3362	777.3	0	.	n	.	0	T695C	SNP	695	695	T	915	915	C	799	C,G,T	740,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26316	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3362	777.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1557	1557	A	820	A	774	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26316	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3362	777.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2191	2191	C	844	C	784	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26316	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3362	777.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2265	2265	A	801	A	766	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26316	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3362	777.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2817	2817	C	771	C,T	722,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26316	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3362	777.3	0	HET	.	.	.	C413T	.	413	413	C	633	633	C	782	C,T	516,207	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1744	folP	855	855	99.88	folP.l6.c4.ctg.1	1543	112.4	1	SNP	p	R229S	1	.	.	685	687	AGC	997	999	AGC	160;159;161	A;G;C	156;154;155	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5416	gyrA	2751	2751	99.96	gyrA.l15.c17.ctg.1	3412	158.3	0	.	p	.	0	D95A	NONSYN	283	285	GAC	604	606	GCC	191;195;195	G;C;C	179;183;184	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5416	gyrA	2751	2751	99.96	gyrA.l15.c17.ctg.1	3412	158.3	1	SNP	p	S91F	1	.	.	271	273	TTC	592	594	TTC	182;181;181	T;T;C	174;172;172	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1438	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1427	100.6	1	SNP	p	G45D	1	.	.	133	135	GAC	616	618	GAC	205;208;208	G;A;C	189;186;190	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	720	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	910	78.4	0	.	n	.	0	A197.	DEL	197	197	A	488	488	A	174	A	158	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4846	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3041	158.7	1	SNP	p	D86N	0	.	.	256	258	GAC	690	692	GAC	199;197;200	G,T;A;C	185,1;181;188	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4846	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3041	158.7	1	SNP	p	R87I	0	.	.	259	261	CGT	693	695	CGT	201;204;204	C;G;T	188;191;186	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4846	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3041	158.7	1	SNP	p	R87W	0	.	.	259	261	CGT	693	695	CGT	201;204;204	C;G;T	188;191;186	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4846	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3041	158.7	1	SNP	p	S87R	1	.	.	259	261	CGT	693	695	CGT	201;204;204	C;G;T	188;191;186	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4846	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3041	158.7	1	SNP	p	S88P	0	.	.	262	264	TCC	696	698	TCC	202;200;200	T;C;C	188;186;188	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3586	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2586	137.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1523	1525	GGC	173;171;174	G;G;C	163;162;165	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1249	1251	GCA	190;190;192	G;C;A	179;181;183	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1252	1254	ATC	194;195;195	A;T;C	184;185;182	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1264	1266	GTG	191;195;192	G;T;G	181;184;183	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1264	1266	GTG	191;195;192	G;T;G	181;184;183	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1768	1770	ACC	170;170;169	A;C;C	155;158;158	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1822	1824	GCG	171;172;169	G;C,G;G	151;135,1;142	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1822	1824	GCG	171;172;169	G;C,G;G	151;135,1;142	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1945	1947	GGC	165;163;163	G;G;C	147;144;144	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1954	1956	GGC	151;145;145	G;G;C	135;127;123	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3858	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2473	155.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1972	1974	CCG	117;119;118	C,G;C;G	93,5;92;90	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5596	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3159	176.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1690	1692	CCG	193;194;192	C;C;G,C	173;181;174,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2046	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1772	114.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	390	392	GGC	169;171;171	G;G;C	151;152;152	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2046	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1772	114.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	572	572	C	153	C	139	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	0	.	p	.	0	T26A	NONSYN	76	78	ACC	405	407	GCC	272;267;273	G;C;C	245;241;245	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	441	443	GAA	264;264;265	G;A;A	241;246;246	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	729	731	GAT	231;228;233	G,A;A;T	216,1;213;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	852	854	TCA	233;232;231	T;C;A	208;209;208	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	0	.	p	.	0	D212N	NONSYN	634	636	GAT	963	965	AAT	253;250;249	A;A;T	236;233;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	0	.	p	.	0	Y216D	NONSYN	646	648	TAT	975	977	GAT	236;238;236	G,A,T;A;T	218,1,1;223;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	981	983	GTC	230;232;230	G;T,G;C,A	218;216,1;215,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1311	1313	GCA	220;222;223	G;C;A	201;201;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	1	SNP	p	G120K	1	.	.	358	360	AAG	687	689	AAG	239;237;236	A;A;G	219;218;216	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	1	SNP	p	D121N	0	.	.	361	363	GAC	690	692	GAC	236;238;234	G;A;C,T	218;218;217,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1636	173.8	1	SNP	p	A121D	1	.	.	361	363	GAC	690	692	GAC	236;238;234	G;A;C,T	218;218;217,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10574	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4834	218.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1188	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1057	112.0	1	SNP	p	V57M	1	.	.	169	171	ATG	521	523	ATG	242;240;241	A;T;G	223;221;223	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	12974	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2706	478.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
